Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors.

Cadarette SM, Solomon DH, Katz JN, Patrick AR, Brookhart MA.

Osteoporos Int. 2011 Mar;22(3):943-54. doi: 10.1007/s00198-010-1309-z. Epub 2010 Jun 8.

PMID:
20532481
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Measuring and improving adherence to osteoporosis pharmacotherapy.

Cadarette SM, Burden AM.

Curr Opin Rheumatol. 2010 Jul;22(4):397-403. doi: 10.1097/BOR.0b013e32833ac7fe. Review.

PMID:
20498602
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial.

Schwartz AV, Bauer DC, Cummings SR, Cauley JA, Ensrud KE, Palermo L, Wallace RB, Hochberg MC, Feldstein AC, Lombardi A, Black DM; FLEX Research Group.

J Bone Miner Res. 2010 May;25(5):976-82. doi: 10.1002/jbmr.11.

PMID:
20200926
[PubMed - indexed for MEDLINE]
4.

Validating studies of adherence through the use of control outcomes and exposures.

Brookhart MA, Patrick AR, Shrank WH, Dormuth CR.

Am J Hypertens. 2010 Feb;23(2):110. doi: 10.1038/ajh.2009.232. No abstract available.

PMID:
20087324
[PubMed - indexed for MEDLINE]
5.

Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis.

Imaz I, Zegarra P, González-Enríquez J, Rubio B, Alcazar R, Amate JM.

Osteoporos Int. 2010 Nov;21(11):1943-51. doi: 10.1007/s00198-009-1134-4. Epub 2009 Dec 5. Review.

PMID:
19967338
[PubMed - indexed for MEDLINE]
6.

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis.

Höer A, Seidlitz C, Gothe H, Schiffhorst G, Olson M, Hadji P, Häussler B.

Patient Prefer Adherence. 2009 Nov 3;3:25-30.

PMID:
19936142
[PubMed]
Free PMC Article
7.

On guidelines for comparative effectiveness research using nonrandomized studies in secondary data sources.

Schneeweiss S.

Value Health. 2009 Nov-Dec;12(8):1041. doi: 10.1111/j.1524-4733.2009.00607.x. Epub 2009 Sep 10. No abstract available.

PMID:
19744290
[PubMed - indexed for MEDLINE]
8.

Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence.

Rabenda V, Hiligsmann M, Reginster JY.

Expert Opin Pharmacother. 2009 Oct;10(14):2303-15. doi: 10.1517/14656560903140533. Review.

PMID:
19640210
[PubMed - indexed for MEDLINE]
9.

Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials.

Wilkes MM, Navickis RJ, Chan WW, Lewiecki EM.

Osteoporos Int. 2010 Apr;21(4):679-88. doi: 10.1007/s00198-009-0991-1. Epub 2009 Jul 2. Review.

PMID:
19572092
[PubMed - indexed for MEDLINE]
10.

A framework for planning and critiquing medication compliance and persistence research using prospective study designs.

Gwadry-Sridhar FH, Manias E, Zhang Y, Roy A, Yu-Isenberg K, Hughes DA, Nichol MB.

Clin Ther. 2009 Feb;31(2):421-35. doi: 10.1016/j.clinthera.2009.02.021. Review.

PMID:
19302915
[PubMed - indexed for MEDLINE]
11.

Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment.

Geusens P.

Curr Osteoporos Rep. 2009 Mar;7(1):12-7. Review.

PMID:
19239824
[PubMed - indexed for MEDLINE]
12.

Impact of osteoporosis treatment adherence on fracture rates in North America and Europe.

Siris ES, Selby PL, Saag KG, Borgström F, Herings RM, Silverman SL.

Am J Med. 2009 Feb;122(2 Suppl):S3-13. doi: 10.1016/j.amjmed.2008.12.002. Review.

PMID:
19187810
[PubMed - indexed for MEDLINE]
13.

Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: a retrospective case-control analysis.

Cotté FE, Mercier F, De Pouvourville G.

Clin Ther. 2008 Dec;30(12):2410-22. doi: 10.1016/j.clinthera.2008.12.019.

PMID:
19167600
[PubMed - indexed for MEDLINE]
14.

Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures.

Sheehy O, Kindundu C, Barbeau M, LeLorier J.

Osteoporos Int. 2009 Sep;20(9):1583-94. doi: 10.1007/s00198-008-0829-2. Epub 2009 Jan 20.

PMID:
19153677
[PubMed - indexed for MEDLINE]
15.

Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates.

Roughead EE, Ramsay E, Priess K, Barratt J, Ryan P, Gilbert AL.

Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):69-75. doi: 10.1002/pds.1687.

PMID:
19111013
[PubMed - indexed for MEDLINE]
16.

RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction.

Curtis JR, Westfall AO, Cheng H, Saag KG, Delzell E.

Osteoporos Int. 2009 Jun;20(6):973-8. doi: 10.1007/s00198-008-0772-2. Epub 2008 Oct 23.

PMID:
18946630
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effectiveness of bisphosphonate therapy in a community setting.

Feldstein AC, Weycker D, Nichols GA, Oster G, Rosales G, Boardman DL, Perrin N.

Bone. 2009 Jan;44(1):153-9. doi: 10.1016/j.bone.2008.09.006. Epub 2008 Sep 26.

PMID:
18926939
[PubMed - indexed for MEDLINE]
18.

Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures .

Meijer WM, Penning-van Beest FJ, Olson M, Herings RM.

Curr Med Res Opin. 2008 Nov;24(11):3217-22. doi: 10.1185/03007990802470241. Epub 2008 Oct 14.

PMID:
18922215
[PubMed - indexed for MEDLINE]
19.

The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates.

Rietbrock S, Olson M, van Staa TP.

QJM. 2009 Jan;102(1):35-42. doi: 10.1093/qjmed/hcn130. Epub 2008 Oct 8.

PMID:
18842684
[PubMed - indexed for MEDLINE]
Free Article
20.

Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians.

Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Forciea MA, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians.

Ann Intern Med. 2008 Sep 16;149(6):404-15.

PMID:
18794560
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk